January 21, 2022

Genetic prior authorization waiver has expired

Since we began transitioning genetic testing to the new Prior Authorization and Notification platform in June 2021, we have offered a prior authorization penalty waiver for genetic and molecular tests.

On Jan. 1, 2022, the penalty waiver expired. This means for those genetic and molecular tests that require prior authorization/advanced notification, ordering providers must request prior authorization using the Prior Authorization and Notification platform or by calling 877-303-7736.

Performing laboratories can submit advance notifications. If a test requires prior authorization with clinical criteria, the request must be submitted by the ordering provider.

For the current list of genetic and molecular tests that require prior authorization/advance notification, please go to UHCprovider.com/paan > Advance Notification and Plan Requirement Resources.

Prior authorization/advance notification training
UnitedHealthcare is offering live training sessions for the genetic and molecular testing prior authorization/advance notification (PAAN) program. To register for training, please visit the UnitedHealthcare genetic and molecular testing prior authorization/advance notification (PAAN) web page.

Questions?
For more information about the genetic and molecular lab testing prior authorization/advance notification program, please visit the UnitedHealthcare genetic and molecular testing prior authorization/advance notification (PAAN) web page and review the genetic and molecular lab testing PAAN FAQs.

PCA-1-21-21-04581